Morgan Stanley Resumes Coverage of Covidien (COV), Baxter (BAX), Becton Dickinson (BDX), Hospira (HSP), Integra (IART)
More News related to BAX
- Morgan Keegan Starts BDX, HAE, BCR, MASI, COO at Outperform, BAX, HRC, COV, TFX, ISRG at Market Perform
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Baxter (BAX) Raises Qtr Dividend 12% to $0.29/Share, 2.1% Yield
- Baxter Raises Quarterly Dividend
- New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
More News related to BDX
- Citi Starts Beckton Dickinson (BDX) at Buy, $85 Price Target
- BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
- Becton, Dickinson (BDX) Boosts Qtr. Dividend by 12.1%, Authorizes 10M Share Buyback
- BD Board Increases Dividend and Authorizes Additional Share Repurchases
- Notable Mergers and Acquisitions of the Day 11/23: GMCR/DDRX, PBCT/FIF, CIEN, BDX, IDTI
More News related to COV
- Nuvo Research announces organizational changes
- Covidien Completes Sale of Oxygen Therapy Product Line
- Chart's CAIRE Completes Acquisition of Covidien's Oxygen Therapy Business
- Covidien to Present at Piper Jaffray Health Care Conference
- Covidien (COV) Announces FDA Extends Review of NDA for Exalgo
After the close today, Morgan Stanley resumed coverage of several stocks in the Healthcare sector:
with an Overweight rating:
with an Underweight rating:
- Integra LifeSciences (Nasdaq: IART)
Related Categories
New CoverageStocks Mentioned
+0.22
-0.11Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
